Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Endocrinology|March 26, 2005
Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetesIvana Cvetkovic, Yousef Al-Abed, Djordje Miljkovic, et al.
Molecules (Basel, Switzerland)|September 29, 2018
Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma CellsMaria Sofia Basile, Emanuela Mazzon, Tamara Krajnovic, et al.
Dalton Transactions (Cambridge, England : 2003)|June 7, 2016
Antiproliferative activity of ruthenium(ii) arene complexes with mono- and bidentate pyridine-based ligandsStefan Richter, Sushma Singh, Dijana Draca, et al.
Investigational New Drugs|February 2, 2019
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivoSvetlana Paskas, Emanuela Mazzon, Maria Sofia Basile, et al.
Chemmedchem|January 3, 2019
Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell LinesAntonio Buzharevski, Svetlana Paskas, Menyhárt-Botond Sárosi, et al.
Chemmedchem|June 2, 2017
CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase PathwayRobert Kuhnert, Menyhárt-Botond Sárosi, Sven George, et al.
European Journal of Pharmacology|May 19, 2009
The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitisMarco Donia, Sanja Mijatovic, Danijela Maksimovic-Ivanic, et al.
Journal of Cellular Physiology|December 8, 2007
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitusStanislava Stosic-Grujicic, Ivana Stojanovic, Danijela Maksimovic-Ivanic, et al.
Pageof 5